These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14520703)

  • 1. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
    Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
    Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer.
    Alguacil J; Porta M; Malats N; Kauppinen T; Kogevinas M; Benavides FG; Partanen T; Carrato A;
    Carcinogenesis; 2002 Jan; 23(1):101-6. PubMed ID: 11756230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group.
    Alguacil J; Kauppinen T; Porta M; Partanen T; Malats N; Kogevinas M; Benavides FG; Obiols J; Bernal F; Rifà J; Carrato A
    Ann Occup Hyg; 2000 Aug; 44(5):391-403. PubMed ID: 10930502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Jariod M; Grimalt JO; Rifà J; Carrato A; Guarner L; Salas A; Santiago-Silva M; Corominas JM; Andreu M; Real FX
    Lancet; 1999 Dec 18-25; 354(9196):2125-9. PubMed ID: 10609819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toenail concentrations of trace elements and occupational history in pancreatic cancer.
    Camargo J; Pumarega JA; Alguacil J; Sanz-Gallén P; Gasull M; Delclos GL; Amaral AFS; Porta M
    Environ Int; 2019 Jun; 127():216-225. PubMed ID: 30928845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Alguacil J; Morales E; Fernandez E; Corominas JM; Carrato A; Guarner L; Real FX;
    Pancreas; 2007 Aug; 35(2):135-41. PubMed ID: 17632319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos.
    Husgafvel-Pursiainen K; Hackman P; Ridanpää M; Anttila S; Karjalainen A; Partanen T; Taikina-Aho O; Heikkilä L; Vainio H
    Int J Cancer; 1993 Jan; 53(2):250-6. PubMed ID: 8425762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [K-ras gene mutations of asbestos and welding-fumes related human lung cancer].
    Huang B; Liu B; Xu M; You B
    Wei Sheng Yan Jiu; 2000 Jan; 29(1):7-9. PubMed ID: 12725029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
    Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
    Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Guarner L; Carrato A; Rifà J; Salas A; Corominas JM; Andreu M; Real FX
    J Epidemiol Community Health; 1999 Nov; 53(11):702-9. PubMed ID: 10656099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
    Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
    Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study.
    Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental occupational exposure to combustion products, metals, silica and asbestos and risk of childhood leukaemia: Findings from the Childhood Cancer and Leukaemia International Consortium (CLIC).
    Onyije FM; Olsson A; Erdmann F; Magnani C; Petridou E; Clavel J; Miligi L; Bonaventure A; Ferrante D; Piro S; Peters S; Vermeulen R; Kromhout H; Schüz J;
    Environ Int; 2022 Sep; 167():107409. PubMed ID: 35908390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
    Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
    Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
    Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
    J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.